CMIP is a negative regulator of T cell signaling

Julie Oniszczuk,Kelhia Sendeyo,Cerina Chhuon,Berkan Savas,Etienne Cogné,Pauline Vachin,Carole Henique,Ida Chiara Guerrera,Giuseppe Astarita,Vincent Frontera,Andre Pawlak,Vincent Audard,Dil Sahali,Mario Ollero

DOI: https://doi.org/10.1038/s41423-019-0266-5

Abstract:Upon their interaction with cognate antigen, T cells integrate different extracellular and intracellular signals involving basal and induced protein-protein interactions, as well as the binding of proteins to lipids, which can lead to either cell activation or inhibition. Here, we show that the selective T cell expression of CMIP, a new adapter protein, by targeted transgenesis drives T cells toward a naïve phenotype. We found that CMIP inhibits activation of the Src kinases Fyn and Lck after CD3/CD28 costimulation and the subsequent localization of Fyn and Lck to LRs. Video microscopy analysis showed that CMIP blocks the recruitment of LAT and the lipid raft marker cholera toxin B at the site of TCR engagement. Proteomic analysis identified several protein clusters differentially modulated by CMIP and, notably, Cofilin-1, which is inactivated in CMIP-expressing T cells. Moreover, transgenic T cells exhibited the downregulation of GM3 synthase, a key enzyme involved in the biosynthesis of gangliosides. These results suggest that CMIP negatively impacts proximal signaling and cytoskeletal rearrangement and defines a new mechanism for the negative regulation of T cells that could be a therapeutic target.